Evan Loh, M.D. - Accomplished Pharmaceutical Executive and Physician-Scientist
Professional Overview
Evan Loh, M.D., is an experienced pharmaceutical executive and physician-scientist with a proven track record of driving innovation and fostering the development of groundbreaking therapies. As the President, Chief Operating Officer, and Chief Medical Officer at Paratek Pharmaceuticals, he leverages his deep industry expertise and medical background to guide the company's strategic direction and oversee the successful commercialization of its novel antibiotic treatments.
Experience Summary
Current Role
As the President, COO, and CMO of Paratek Pharmaceuticals, Dr. Loh is responsible for leading the company's overall operations, clinical development, and regulatory strategies. Under his leadership, Paratek has achieved significant milestones, including the FDA approval and commercial launch of its lead product, a first-in-class tetracycline antibiotic. Dr. Loh also serves as a Director on the company's Board, providing strategic guidance and oversight to ensure the organization's continued growth and success.
Career Progression
Prior to joining Paratek, Dr. Loh held senior leadership roles at several prominent pharmaceutical companies. He served as a Senior Vice President at Pfizer, where he oversaw the development and commercialization of numerous innovative therapies. Earlier in his career, he held various positions of increasing responsibility at Wyeth, including roles as a Senior Director, Assistant Vice President, and Vice President.
In addition to his corporate experience, Dr. Loh has an extensive academic background, having served as an Assistant Professor of Medicine at the University of Pennsylvania Health System and an Instructor in Medicine at Harvard Medical School. He also maintained a clinical practice as an Attending Physician at Brigham and Women's Hospital, where he conducted groundbreaking research and contributed to advancements in patient care.
Academic Background
Dr. Loh received his medical degree from the University of Pennsylvania School of Medicine and completed his internship and residency at Brigham and Women's Hospital. He also received specialized training as a Clinical and Research Fellow at Brigham and Women's Hospital.
Areas of Expertise
- Pharmaceutical product development and commercialization
- Antibiotic and infectious disease therapeutics
- Regulatory affairs and strategic decision-making
- Translational research and physician-scientist leadership
- Cross-functional team management and collaboration
Professional Impact
Throughout his distinguished career, Dr. Loh has been instrumental in the development and successful launch of multiple innovative pharmaceutical products. His leadership and expertise have significantly contributed to advancements in the treatment of infectious diseases and have helped improve patient outcomes. As a physician-scientist, he has also made valuable contributions to the medical community through his research and clinical practice.
Conclusion
With his extensive experience, medical expertise, and proven track record of success, Dr. Evan Loh is a highly respected pharmaceutical executive and a valuable asset to Paratek Pharmaceuticals. His strategic vision, scientific acumen, and commitment to innovation position him as a leader in the industry, driving the development and commercialization of transformative therapies that address critical unmet medical needs.
